S1 – 1: Lian-Da Li- Research advances in ginseng

S1 – 2: Hua Zhou – Involvement of RISK and NO pathways in the cardioprotective effect of ginseng

S1 – 3: Chong-Zhi Wang and Chun-Su Yuan –American Ginseng and Cancer Chemoprevention

S1 – 4: Aiping Lu - The molecular networks of herbal products used to treat rheumatoid arthritis patients

S1 – 5: William Jia – Drug discovery from traditional Chinese medicinal herbs: An informatics approach through
Saphron database

S1 – 6: Ven Tan - Setting up the Sydney Model of Integrative Medicine

S1 – 7: Kelvin Chan – The way forward with TCM research

S2 – 1: Lawrence Helson – Development of parenteral curcumin formulations for clinical applications

S2 – 2: Hana Rabeh, Yves Bureau and Michael Woodbury – Translational study of standardized zembrin extract and mesembrenone targeting pde-4 (phosphodiesterase subtype 4) for regulation of mood and cognition

S2 – 3: Michael Woodbury - Proof of concept of randomized controlled study of CurcuminC-3 Complex as adjunct treatment in schizophrenia: effects on negative and depressive symptoms
S2 – 4: Kristen J Terpstra and Yves Bureau – Neuroprotective effects of liposomal-formulated curcumin (lipocurc exhibiting multiple cns actions, in modifying the phenotype of park-7 knockout rat paradigm of Parkinson’s disease

S2 – 5: Simon Chiu – Targeting Epigenetics-Transcription regulation in transforming Ginseng from Herbal supplement to CNS drug lead: RCT findings of Ginsana-115 in schizophrenia

S3 – 1: C. Robin Buell - Drug development from medicinal plants: transcriptomic and metabolomic approaches

S3 – 2: Dan Brown – Ginseng cultivar development

S3 – 3: Chao Sun and SL Chen – Medicinal plant genomics

S3 – 4: Stephen Barnes – Metabolomics and cataract

S3 – 5: Helen Kim – Health benefits of polyphenolic anti-oxidants

S3 – 6: Ricky N.S. Wong – MicroRNAs as mediators of ginseng action on angiogenesis.

S4 – 1: Qingping Feng – Ginseng and ischemia reperfusion injury

S4 – 2: Morris Karmazyn – Prevention and Reversal of Post-infarction Remodeling and Heart Failure by North American Ginseng

S4 – 3: Elana Jovanovski and V. Vuksan - Potential of ginseng to improve vascular function-evidence from RCT’s

S5 – 1: Ping-Chung Leung – Creating a simple herbal formula for the healing of chronic ulcers – a ten years’ pursue, from bench to clinical studies

S5 – 2: William Jia – S111, a potent antidepressant discovered by a novel approach from ginseng

S5 – 3: Denis Kay, Jackalina VanKampen, William Jia & Harold A. Robertson – Ginsenosides and the prophylactic treatment of Parkinson’s: a new approach to treating neurological disorders

S5 – 4: Guang Liang – Discovery and evaluation of anti-inflammatory derivatives from natural bioactive curcumin

S5 – 5: Siyaram Pandey – Selective induction of cancer cell death by natural products from dandelion root, turmeric and long pepper extracts

S5 – 6: Jeremy Burton – Stepping over the horizon: Potential future uses for probiotics

Workshops

W1 – 1: Ron Smith and Connie Kehler – Field and forest to quality finished products: integrating traceability, sustainability, ethics and safetyW1 – 2: Danna J Leaman – Conservation and sustainability

W1 – 3: Carl Atkinson – Ginseng production: Challenges facing Ontario ginseng growers

W1 – 4: De-Qiang Dou – Characteristics of ginseng cultivated under mountainous forest conditions

W1 – 5: Antoine Bily – Private sector perspectives from Naturex

W1 – 6: Sean Westerveld – An overview of medicinal herb production in Ontario

W1 – 7: Sem Ponnambalam and Sara Sarker – Golden rules of superfood success in Canada

W1 – 8: Krista Coventry – Health claim opportunities for natural bioactives

W2 – 1: Kelvin Chan – Chinese Materia Medica and Chinese herbal products

W2 – 2: Ed Lui and Hou Zhou – International Organization of Standardization program

W2 – 3: Ammar Saleem and John Arnason – Standardization of herbal extracts

W3 (I) – 1: Carmen Tamayo – Future of NHPs: Developing complex therapeutics in the 21st century

W3 (I) – 2: Paul Saunders – Clinical perspective on priority medicinal herbs for future R&D

W3 (I) – 3: Krista Coventry – Best Practices in Clinical Trials for Natural Health Products

W3 (II) – 1: Mary Alton-Mackey – Functional ingredients and functional foods – Getting it right

W3 (II) – 2: Ed Lui – Preclinical and safety consideration: ginseng case study

Oral Abstracts: click here

Poster Abstracts: click here